Journals / Dicle Tıp Dergisi / 2015 / Cilt: 42 - Sayı: 2

Sexual dysf unction in a p atient with rheumatoid arthritis treated with adalimumab

Adalimumab tedavisi alan romatoid artritli hastada seksüel disfonksiyon

Pages
262–264
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a case of sexual dysfunction developing after adalimumab treatment in a man patient with RA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Rheumatoid arthritis (RA) is a chronic, systemic and inflammatory disease characterized by symmetric polyarthritis and arthralgia, morning stiffness, fatigue and rheumatoid nodules.
📊
Key Findings & Data:Both women and men with RA suffer from decreased sexual function.
💡
Conclusion & Impact:We present a case of sexual dysfunction developing after adalimumab treatment in a man patient with RA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Rheumatoid arthritis (RA) is a chronic, systemic and inflammatory disease characterized by symmetric polyarthritis and arthralgia, morning stiffness, fatigue and rheumatoid nodules. Multifactorial etiology such as genetic, infectious, hormonal or environmental factors contribute to disease susceptibility. However, clear etiology is not still defined. Both women and men with RA suffer from decreased sexual function. Also, many factors include disease activity, medications or psychological disorders can affect sexual health in a patients with RA. Sexual health is important for human life. However, often overlooked is the association between RA and sexual problems in clinical practice. We present a case of sexual dysfunction developing after adalimumab treatment in a man patient with RA.

Özet

Romatoid artrit (RA) simetrik poliartrit ve artralji, sabah tutukluğu, yorgunluk ve romatoid nodüllerle karakterize kronik, sistemik ve enflamatuar hastalıktır. Genetik, enfeksiyöz, hormonal veya çevresel faktörleri içeren multifaktöriyel etkenler RA gelişimine katkıda bulunabilir. Bununla birlikte kesin etiyoloji hala tanımlanmamıştır. Hem erkek hem de bayan RAlı hastalar azalmış seksüel fonksiyonlardan şikayetçidir. Ayrıca, RAlı hastalarda hastalık aktivitesi, ilaçlar ve psikolojik problemler seksüel fonksiyonları etkileyebilmektedir. Cinsel sağlık insan yaşamında önemlidir. Buna rağmen klinik pratikte RA ile seksüel problemler arasındaki ilişki sıklıkla dikkate alınmamaktadır. Biz RAlı bir erkek hastada adalimumab başlandıktan sonra gelişen seksüel disfonksiyon vakasını sunuyoruz.

🔖

Cite This Article

YAZMALAR, L., SARIYILDIZ, M. A., BATMAZ, I. (2015). Sexual dysf unction in a p atient with rheumatoid arthritis treated with adalimumab. Dicle Tıp Dergisi, Cilt: 42 - Sayı: 2, 262–264. https://ajindex.com/articles/348870

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Yazmalar L, Ediz L, Alpayci M, et al. Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. Afr Health Sci 2013;13:47-55
  2. Batmaz I, Sarıyıldız MA, Dilek B, et al. Sexuality of men with fibromyalgia: what are the factors that cause sexual dysfunction? Rheumatol Int 2013;33:1265-1270
  3. Van Berlo WT, van de Wiel HB, Taal E, et al. Sexual functioning of people with rheumatoid arthritis: a multicenter study. Clin Rheumatol 2007;26:30-38
  4. Areskoug-Josefsson K, Oberg U. A literature review of the sexual health of women with rheumatoid arthritis. Muscu- loskeletal Care 2009;7:219-226
  5. El Miedany Y, El Gaafary M, El Aroussy N, et al. Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond. Clin Rheumatol 2012;3:601-606
  6. Oh JS, Heo HM, Kim YG, et al. The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot study. Int J Impot Res 2009;21:372-375
  7. Kreitenberg AJ, Ortiz EC, Arkfeld DG. Priapism after tumor necrosis factor alpha inhibitor use. Clin Rheumatol 2015; DOI 10.1007/s10067-014-2858-x.